These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38166293)

  • 1. Do depressive and anxiety symptoms influence the construct validity of Multiple Sclerosis Walking Scale-12 scores?
    Šilić P; Jones CD; Jeng B; Motl RW
    Rehabil Psychol; 2024 May; 69(2):129-134. PubMed ID: 38166293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence.
    Zheng P; Huynh TLT; Jones CD; Feasel CD; Jeng B; Motl RW
    Mult Scler Relat Disord; 2023 Mar; 71():104552. PubMed ID: 36774829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2.
    Miyazaki Y; Niino M; Takahashi E; Sato C; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S
    Mult Scler Relat Disord; 2024 Sep; 89():105768. PubMed ID: 39003823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-efficacy and Walking Performance in Persons With Multiple Sclerosis.
    Motl RW; Balto JM; Ensari I; Hubbard EA
    J Neurol Phys Ther; 2017 Apr; 41(2):114-118. PubMed ID: 28263255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.
    Pilutti LA; Dlugonski D; Sandroff BM; Suh Y; Pula JH; Sosnoff JJ; Motl RW
    Arch Phys Med Rehabil; 2013 Mar; 94(3):575-8. PubMed ID: 22960049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability.
    Silveira SL; Motl RW; Elmer DJ; Botkin T; Ontiveros T; Williams S; Hubbard EA
    Mult Scler Relat Disord; 2024 Jul; 87():105695. PubMed ID: 38820697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.
    Motl R; Neal W; Backus D; Hebert J; McCully K; Bethoux F; Plummer P; Ng A; Lowman J; Schmidt H; McBurney R; Cutter G
    BMC Neurol; 2024 Oct; 24(1):383. PubMed ID: 39390466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
    Motl RW; Balantrapu S; Pilutti L; Dlugonski D; Suh Y; Sandroff BM; Lane A; Fernhall B
    Eur J Phys Rehabil Med; 2013 Feb; 49(1):59-66. PubMed ID: 22820825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between body composition and walking outcomes in multiple sclerosis.
    Jeng B; Motl RW
    Mult Scler Relat Disord; 2022 Dec; 68():104242. PubMed ID: 36274282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.
    Hobart J; Blight AR; Goodman A; Lynn F; Putzki N
    Neurology; 2013 Apr; 80(16):1509-17. PubMed ID: 23535489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
    Engelhard MM; Schmidt KM; Engel CE; Brenton JN; Patek SD; Goldman MD
    Qual Life Res; 2016 Dec; 25(12):3221-3230. PubMed ID: 27342237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
    Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
    Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis.
    Sikes EM; Cederberg KL; Baird JF; Sandroff BM; Motl RW
    Neurodegener Dis Manag; 2019 Oct; 9(5):267-275. PubMed ID: 31580224
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis.
    Connolly L; Chatfield S; Freeman J; Salter A; Amato MP; Brichetto G; Chataway J; Chiaravalloti ND; Cutter G; DeLuca J; Dalgas U; Farrell R; Feys P; Filippi M; Inglese M; Meza C; Moore NB; Motl RW; Rocca MA; Sandroff BM; Feinstein A
    Mult Scler Relat Disord; 2024 Oct; 90():105798. PubMed ID: 39213864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.